Cell and Gene Meeting on the Mesa 2024
October 7-9, 2024
Phoenix, AZ
The Cell & Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine (ARM), stands as a flagship annual gathering for senior executives and industry leaders dedicated to advancing regenerative medicine. This conference is pivotal in addressing the intricate challenges of commercializing cell and gene therapies, covering a broad spectrum from clinical trial innovations and digital manufacturing advancements to enhancing patient accessibility and scaling up production capabilities. With a robust agenda that includes deep dives into the future of advanced therapies, discussions on ethical considerations, and insights into financing and regulatory landscapes, the event serves as a vital platform for driving the translation of cutting-edge research into clinical applications.
PRC Clinical is a Contract Research Organization (CRO) and proud member of the ARM, recognized for our extensive experience and expertise in clinical trial management for regenerative medicine investigational products. Since 2002, our study teams have been at the forefront of clinical trials in regenerative medicine, starting with pre-stem-cell and gene therapy in early DNA plasmid studies for musculoskeletal and other disease therapies. This early involvement has evolved into a robust history of conducting complex studies utilizing stem cell and gene therapies.